UTAH MEDICAL PRODUCTS INC
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $11.3M | $13.9M | $16.6M | $16.5M | $14.8M | $10.8M | $14.7M | $18.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $826.0K | $730.0K | $623.0K | $612.0K | $636.0K | $655.0K | $700.0K | $765.0K |
| Amortization | $2.1M | $2.1M | $5.7M | $6.4M | $6.6M | $6.5M | $6.1M | — |
| Stock-Based Compensation | $373.0K | $256.0K | $225.0K | $183.0K | $166.0K | $160.0K | $113.0K | $64.0K |
| Net Cash from Operating Activities | $14.7M | $14.8M | $22.3M | $21.1M | $21.2M | $20.1M | $17.1M | $16.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $371.0K | $230.0K | $639.0K | $809.0K | $552.0K | $860.0K | $540.0K | $402.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-371.0K | $-208.0K | $-639.0K | $-818.0K | $-552.0K | $-860.0K | $-21.5M | $534.0K |
| Financing Activities | ||||||||
| Dividends Paid | $4.0M | $4.3M | $4.3M | $3.2M | $11.5M | $4.1M | $4.1M | $4.0M |
| Stock Repurchases | $8.4M | $20.0M | $0 | $2.5M | $0 | $7.0M | $398.0K | $1.2M |
| Net Cash from Financing Activities | $-12.3M | $-23.8M | $-4.2M | $-5.5M | $-10.9M | $-10.7M | $-4.2M | $-4.8M |
| Net Change in Cash | $2.8M | $-9.9M | $17.8M | $14.1M | $9.4M | $8.8M | $-8.3M | $11.2M |
| Free Cash Flow | $14.3M | $14.6M | $21.6M | $20.3M | $20.7M | $19.3M | $16.5M | $16.4M |